Lexicon Pharmaceuticals Inc. (LXRX)
NASDAQ: LXRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 1.76 0.00%
LXRX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $783.12M
- EPS (TTM)
- -$0.16
- Dividend yield
- None
- 52-week range
- 1.10 – 2.68
- Day range
- 1.71 – 1.77
- Volume / Avg
- 1.10M / 2.91M
- Beta
- —
- Shares outstanding
- 444.96M
- Next earnings
- Nov 5, 2026
52-week range
LXRX stock today
Shares of Lexicon Pharmaceuticals (LXRX) finished higher on Oct 7 at $1.76, a gain of 0.57% or $0.01 per share, versus the S&P 500's 0.22% decline. Trading was light, with 1.10M shares changing hands, about 38% of the average daily volume. At this level, LXRX sits in the middle of its 52-week range of $1.10 to $2.68: 34.3% below the high, set on Jun 30, 2026 and 60.0% above the low.
LXRX is up 53.0% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 15.8%. Lexicon Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$0.16), so its P/E ratio is not meaningful. Lexicon Pharmaceuticals's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Lexicon Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- The Woodlands, TX
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.05
Lexicon Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GERNGeron Corporation | 1.20 | -0.83% | $770.97M | vs LXRX |
| IMMXImmix Biopharma Inc. | 9.49 | -1.56% | $786.75M | vs LXRX |
| HELPHelus Pharma Inc. | 10.51 | -2.32% | $767.86M | vs LXRX |
| IVAInventiva S.A. American Depository Shares | 3.37 | -2.75% | $794.88M | vs LXRX |
| ANNXAnnexon Inc. | 4.01 | -0.50% | $760.21M | vs LXRX |
| APMDApnimed Inc. | 18.04 | -3.27% | $751.02M | vs LXRX |
| VSTMVerastem Inc. | 8.27 | +6.65% | $748.51M | vs LXRX |
| GYREGyre Therapeutics Inc. | 7.04 | -0.56% | $746.48M | vs LXRX |
Indexes, lists and sector
Largest Health Care stocks
Lexicon Pharmaceuticals stock FAQ
What is Lexicon Pharmaceuticals's stock price today?
LXRX last traded at $1.76 as of Oct 7, 4:00 PM EDT, up 0.57% on the day. Prices are delayed at least 15 minutes.
Does Lexicon Pharmaceuticals pay a dividend?
No. Lexicon Pharmaceuticals does not currently pay a regular cash dividend.
When is Lexicon Pharmaceuticals's next earnings date?
Lexicon Pharmaceuticals is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.05.
Has LXRX ever split its stock?
Yes. The most recent LXRX stock split was a 1-for-7 split on May 21, 2015.
What is the LXRX 52-week high?
The 52-week high for LXRX is $2.68 and the 52-week low is $1.10. The stock is currently 34.3% below its high.